(Q38746077)

6 September 2017

title

Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study (English)

1 reference

6 September 2017

0 references

1 reference

Fabian Hoti

3

0 references

Jari Tiihonen

1

object named as

Jari Tiihonen

1 reference

6 September 2017

Antti Tanskanen

2

1 reference

6 September 2017

Pia Vattulainen

4

1 reference

6 September 2017

Heidi Taipale

5

1 reference

6 September 2017

Juha Mehtälä

6

1 reference

6 September 2017

Markku Lähteenvuo

7

1 reference

6 September 2017

publication date

1 June 2017

1 reference

6 September 2017

published in

The Lancet Psychiatry

1 reference

6 September 2017

volume

4

1 reference

6 September 2017

issue

7

1 reference

6 September 2017

page(s)

547-553

1 reference

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Can non-pharmacological interventions prevent relapse in adults who have recovered from depression? A systematic review and meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Meta-analysis of relapse prevention antidepressant trials in depressive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Pharmacologic approaches to treatment resistant depression: Evidences and personal experience

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

From prescription drug purchases to drug use periods – a second generation method (PRE2DUP).

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Lithium treatment and risk of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Lithium treatment and risk for dementia in adults with bipolar disorder: population-based cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2817%2930134-7

7 January 2021

10.1016/S2215-0366(17)30134-7

Identifiers

DOI

1 reference

6 September 2017

1 reference